clinical trials

An innovative device decentralizes blood collection and unlocks a new horizon for blood-based biomarker discovery.

Researchers developed a continuously updated database to help computational models screen combinatorial drugs for evasive diseases.

There are currently no FDA-approved drugs to treat vitiligo, an autoimmune disease that kills skin pigment cells. But a phase III study of a drug used to treat atopic dermatitis may be the first to get the FDA seal of approval.

A novel, non-invasive treatment using electrical currents exploits physiological properties of dividing cancer cells to prolong survival and augment current therapies.

On a quest to bring new a new hemophilia gene therapy to the clinic, one research team leapt over hurdle after hurdle to produce enough viral therapeutics to treat a large number of patients.

Amongst a plethora of stem cells, which cell type should scientists choose?

A new product takes on the tricky process of tissue regeneration.

The company plans to develop more specialized, antibody-based GPCR drugs to treat a myriad of diseases. They recruited a leader in overseeing successful clinical trials to get the job done.

Clinicians, researchers, and communicators are developing more effective strategies to disseminate information about clinical trials to reach a wider audience. They ultimately expect that this will lead to more inclusive trials.

People with autism often struggle to understand nonverbal communication. Psychologist Suzanne Scherf wants to help them learn how to interpret this style of communication through the narrative power of video games.